Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Veranex Hires FDA Veteran Jose Pablo Morales, MD as CMO
People, Supplier News

Veranex Hires FDA Veteran Jose Pablo Morales, MD as Chief Medical Officer

New Veranex CMO Dr. Morales was most recently senior medical adviser in the FDA's Office of Clinical Policy.

Jose Pablo Morales, MD. Photo: Veranex

Veranex, an “Innovation CRO” (iCRO) specializing in end-to-end medtech development, has appointed Jose Pablo Morales, MD as its new chief medical officer (CMO).

Dr. Morales joins Veranex after a career at the U.S. Food and Drug Administration (FDA), where he provided clinical and regulatory oversight for over 1,000 medical device submissions, including PMAs, IDEs, and breakthrough designations. He held a leading role in implementing and adopting the FDA’s Early Feasibility Studies (EFS) pathway.

Dr. Morales was most recently senior medical adviser in the Office of Clinical Policy and guided cross-center initiatives on complex clinical trials and ethical standards. His background in cardiovascular and implantable device development spans clinical practices and regulatory leadership.

As chief medical officer, he will lead the medical and clinical vision for Veranex’s integrated services platform. The company believes Dr. Morales’ leadership will grow its expertise in modern trial design, real-world evidence generation, and digital innovation.

“Dr. Morales brings unmatched experience in both clinical science and regulatory strategy,” said Lisa Boyle, interim CEO at Veranex. “His leadership will strengthen our ability to help clients innovate confidently while advancing Veranex’s mission to deliver measurable impact across the product lifecycle.”

This hire builds on the company’s recent rollout of the Innovation CRO model, which is a strategy designed to streamline medtech R&D and commercialization in a capital-tight environment.

“Veranex is stepping into an exciting new chapter, and I’m thrilled to join a team that’s redefining how MedTech innovation happens,” said Dr. Morales. “Together, we’ll help turn client concepts into reality with the speed, predictability, regulatory agility, and scientific rigor that sets us apart.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters